1. Home
  2. SLRX vs PRPH Comparison

SLRX vs PRPH Comparison

Compare SLRX & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Salarius Pharmaceuticals Inc.

SLRX

Salarius Pharmaceuticals Inc.

HOLD

Current Price

$0.67

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Logo ProPhase Labs Inc. (DE)

PRPH

ProPhase Labs Inc. (DE)

HOLD

Current Price

$0.33

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLRX
PRPH
Founded
N/A
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
4.1M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
SLRX
PRPH
Price
$0.67
$0.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
297.1K
2.6M
Earning Date
11-14-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,055,000.00
Revenue This Year
N/A
$221.82
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.62
$0.41
52 Week High
$108.00
$9.35

Technical Indicators

Market Signals
Indicator
SLRX
PRPH
Relative Strength Index (RSI) 28.77 50.11
Support Level $0.62 $0.41
Resistance Level $0.68 $1.15
Average True Range (ATR) 0.05 0.09
MACD 0.06 0.01
Stochastic Oscillator 17.86 23.64

Price Performance

Historical Comparison
SLRX
PRPH

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Share on Social Networks: